![NEJM Evidence on Twitter: "Although his time in a clinical trial was limited by drug toxicity, the information gained by the medical community provided the basis for further treatment. @RobertBarkman @SpfldCollege #LCSM # NEJM Evidence on Twitter: "Although his time in a clinical trial was limited by drug toxicity, the information gained by the medical community provided the basis for further treatment. @RobertBarkman @SpfldCollege #LCSM #](https://pbs.twimg.com/media/FM7h5NvVQAMo37n.jpg)
NEJM Evidence on Twitter: "Although his time in a clinical trial was limited by drug toxicity, the information gained by the medical community provided the basis for further treatment. @RobertBarkman @SpfldCollege #LCSM #
NEJM on Instagram: “#ArtificialIntelligence (AI) has tremendous potential to advance clinical practice and the delivery of patient care. A new Review Article…”
![Giovanni Landoni, MD on Twitter: "Eric J. Rubin EIC @NEJM entertains ICU physicians from 14 countries gathered in Tuscany #PratoICM23 >200 major trials published every year after rigorous assessment small RCTs might Giovanni Landoni, MD on Twitter: "Eric J. Rubin EIC @NEJM entertains ICU physicians from 14 countries gathered in Tuscany #PratoICM23 >200 major trials published every year after rigorous assessment small RCTs might](https://pbs.twimg.com/media/FzJZMZrWIAQ8-Ty.jpg:large)